The rise of personalized cancer vaccines is creating a major investment opportunity in tumor sequencing, with analyst projections for Tempus AI reaching $600 million.SummarySubscribe to TodayOnChain membership to read full news summaries and browse without display ads.
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
Tether-backed crypto exchange freezes withdrawals after $7 million leaves custody
A seven-year-old blockchain is permanently abandoning its own network to seek refuge on Ethereum
Cardano Founder Talks About the Lindsay Clancy Trial. “She Should Be Dead”
Metaplanet CEO breaks silence but shareholders say the hard questions remain unanswered
Lululemon Stock Crashed 80%, and Founders are Now Divorcing
Hackers Return 85% of Stolen Bitcoin from Last Week’s Bridge Attack
Strong jobs just triggered a hawkish UBS reversal that could pressure Bitcoin through December
Liquid Gets 3,400 BTC Back After On-Chain Talks; White Hats Keep 598.5 BTC
UK financial watchdog weighs lifting prediction markets ban: Report
